Cardior Pharmaceuticals is a leading clinical-stage biopharmaceutical company pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart. Cardior’s therapeutic approach uses distinctive non-coding RNAs as an innovative platform for addressing the root causes of cardiac dysfunctions. The company aspires to bring transformative therapeutics and diagnostics to patients and thereby make a lasting impact on the treatment of cardiac diseases worldwide. As of May 2, 2024 Cardior Pharmaceuticals GmbH is a wholly owned subsidiary of Novo Nordisk Region Europe A/S.
Company Details
- Employees
- 20
- Founded
- 2016
- Address
- Feodor-Lynen-Str. 15, Hanover,lower Saxony 30625,germany
- Phone
- +49 (0)511-33 85 99 30
- in****@****dior.de
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.cardior.de/
- HQ
- Hanover, Lower Saxony
Cardior Pharmaceuticals Questions
Cardior Pharmaceuticals's helpline number is +49 (0)511-33 85 99 30
Cardior Pharmaceuticals's website is http://www.cardior.de/
Cardior Pharmaceuticals's LinkedIn profile is https://de.linkedin.com/company/cardior-pharmaceuticals
Cardior Pharmaceuticals has
20 employees.
View email and phone details for 20
employees at Cardior Pharmaceuticals.
Cardior Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Cardior Pharmaceuticals's top competitors are
Dicerna Pharmaceuticals, Inc.,
Biontech Se,
4teen4 Pharmaceuticals,
Eqt Life Sciences,
Novo Nordisk,
Eleven Therapeutics,
Bellus Health,
Tubulis Gmbh,
T-Knife Therapeutics,
Debiopharm.
Cardior Pharmaceuticals's support email address is info@cardior.de
Cardior Pharmaceuticals's categories are Pharmaceutical Manufacturing
Cardior Pharmaceuticals's founding year is 2016
